国际皮肤性病学杂志    2002 28 (2): 82-84   ISSN: 2096-5540  CN: 32-1880/R   银屑病病情严重程度评判指标的研究现状 张长宋, 赵天恩, 陈树民 山东省皮肤病性病防治研究所, 济南250022 收稿日期 2001-08-17  修回日期 null  网络版发布日期 null 参考文献  [1] van de Kerkhof PC.The Psoriasis Area and Severity Index and ahemative approaches for the assessment of severity:persisting areas of confusion.Br J Dermatol,1997,137(4):661-662. [2] Harari M,Shani J,Hristakieva E,et al.Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS),and its comparison with the classic method of Psoriasis Area and Severity Index (PASI),before and after elimatotherapy at the Dead-Sea.Int J Dermatol,2000,39(12):913-918. [3] Exam ML,Rapp SR,Feldman SR,et al.Measuring severity of psoriasis:methodological issues.J Dermatol Treat,1996,7:119-124. [4] Marks R.Measurement of the response to treatment in psoriasis.J Dermatol Treat,1996,7 (Suppl 1):S7. [5] Ramsay B,Lawrence CM.Measurement of involved surface area in patients with psoriasis.Br J Dermatol,1991,124(6):565-570. [6] Faust HB,Gonin R,Chuang TY,et al.Reliabihty testing of the Dermatology index of disease severity (DIDS).An index for staging the severity of cutaneous inflammatory disease.Arch Dennatol,1997,133(11):1443-1448. [7] Savolainen L,Kontinen J,Roning J,et al.Applieation of machine vision to assess involved surface in patients with psoriasis.Br J Dermatol,1997,137(3):395-400. [8] Ashcroft DM,Wan Po AL,Williams HC,et al.Clinical measures of dis-ease severity and outcome in psoriasis:a critical appraisal of their quahty.Br J Dermatol,1999,141 (2):185-191. [9] Snellman E,Maljanen T,Aromaa A,et al.Effect of hehotherapy on the cost of psoriasis.Br J Dermatol,1998,138(2):288-292. [10] Feldman SR,Fleischer AB Jr,Reboussin DM,et al.The self-adminis-tered psoriasis area and severity index is valid and reliable.J Invest Dermatol,1996,106(1):183-186. [11] Kirby B,Fortune DG,Bhushan M,et al.The Salford Psoriasis Index:an holistic measure of psoriasis severity.Br J Dermatol,2000,142 (4):728-732. [12] Vardy DA,Guberman D,Lichtenstein DA,et al.Assessment of severity score in patients with psoriasis.Br J Dermatol,1993,129(3):349-350. [13] Gonzalez S,Rajadhyaksha M,Anderson RR.Non-invasive (real-time)imaging of histologic margin of a proliferative skin lesion in vivo.J Invest Dermatol,1998,111(3):538-539. [14] Ashcreft DM,Li Wan Po A,Williams HC,et al.Quality of life measures in psoriasis:a critical appraisal of their quality.J Clin Pharm Ther,1998,23(5):391-398. [15] Mckenna KE,Stem RS.The outcomes movement and new measures of the severity of psoriasis.J Am Acad Dermatol,1996,34(3):534-538. [16] Morgan M,McCreedy R,Simpson J,et al.Dermatology quality of life scales-a measure of the impact of skin diseases.Br J Dermatol,1997,136(2):202-206. [17] Orem A,Deger O,Cimsit G,et al.Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis.Clin Claim Aeta,1997,264(1):49-56. [18] De Pita O,Ruffelli M,Cadoni S,et al.Psoriasis:comparison of immuno-logical markers in patients with acute and remission phase.J Dermatol Sci,1996,13(2):118-24. 通讯作者: